US 10864217
Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy
granted A61KA61K31/167A61K31/18
Quick answer
US patent 10864217 (Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
- Grant date
- Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/167, A61K31/18, A61K31/20, A61K31/27